{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:40:20Z","timestamp":1791211220332,"version":"4.1.0"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>Felodipine (FDP), an antihypertensive drug possesses low water solubility and extensive\nfirst-pass metabolism leading to poor bioavailability. This impelled us to improve its solubility,\nbioavailability, and pharmacodynamic properties through the Nanocrystal (NC) approach.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>FDP-NC were prepared with Poloxamer F125 (PXM) by the antisolvent precipitation\nmethod. The experimental setup aimed at fine-tuning polymer concentration, the proportion of antisolvent\nto solvent, and the duration of ultrasonication for NC formulation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Optimized formulation was characterized for particle size, solubility, and PDI. Particle reduction\nof 74.96 times was achieved with a 9X solubility enhancement as equated to pure FDP.\nThe morphology of NC was found to be crystalline through scanning electron microscopy observation.\nThe formation of the crystal lattice in FDP-NC was further substantiated by the XRD and\nDSC results. Lowering of the heat of fusion of FDP-NC is a clear indication of size reduction. The\nstability studies showed no substantial change in physical parameters of the FDP-NC as assessed\nby particle size, zeta potential, and drug content.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The crystalline nature and improved solubility of FDP-NC improve the dissolution\nprofile and pharmacodynamic data. The stability study data ensure that FDP-NC can be safely\nstored at 25\u00b0C. It is revealed that FDP-NC had a better release profile and improved pharmacodynamic\neffects as evident from better control over heart rate than FDP.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201818666210729104351","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:34:51Z","timestamp":1627619691000},"page":"625-634","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Appraisal of Felodipine Nanocrystals for Solubility Enhancement and\nPharmacodynamic Parameters on Cadmium Chloride Induced Hypertension\nin Rats"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-0931","authenticated-orcid":true,"given":"Shubhini A.","family":"Saraf","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-6428","authenticated-orcid":true,"given":"Priyanka","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-1047","authenticated-orcid":true,"given":"Samipta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Sonkar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road,\nLucknow, U.P. 226025, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0973-8398.150032","volume":"9","author":"Bastami Z.","year":"2015","unstructured":"Bastami Z.; Taheri A.; Soltanpour S.; Formulation, optimization and characterization of gemfibrozil nanocrystals prepared by wet milling technique. Asian J Pharm 2015,9(1),19-22","journal-title":"Asian J Pharm"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.12.018","volume":"176","author":"Lu Y.","year":"2014","unstructured":"Lu Y.; Wang Z.H.; Li T.; McNally H.; Park K.; Sturek M.; Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. J Control Release 2014,176(1),76-85","journal-title":"J Control Release"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpharm.2009.09.031","volume":"383","author":"Nepal P.R.","year":"2010","unstructured":"Nepal P.R.; Han H-K.; Choi H-K.; Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. Int J Pharm 2010,383(1-2),147-153","journal-title":"Int J Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/IJN.S595","volume":"3","author":"Junghanns J.U.","year":"2008","unstructured":"Junghanns J.U.; M\u00fcller R.H.; Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008,3(3),295-309","journal-title":"Int J Nanomedicine"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1038\/s41598-020-60657-4","volume":"10","author":"Butnariu M.","year":"2020","unstructured":"Butnariu M.; Sarac I.; Samfira I.; Spectrophotometric and chromatographic strategies for exploring of the nanostructure pharmaceutical formulations which contains testosterone undecanoate. Sci Rep 2020,10(1),3569","journal-title":"Sci Rep"},{"key":"ref=6","first-page":"224-229","volume":"63","author":"Butu A.","year":"2015","unstructured":"Butu A.; Rodino S.; Golea D.; Bucu M.; Butnariu M.; Negoescu C.; Dinu-P\u00eervu C.; Liposomal nanodelivery system for protease inhibitor anticancer drug bortezomib 2015,63(2),224-229"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.13005\/bpj\/1920","volume":"13","author":"Coltescu A.R.","year":"2020","unstructured":"Coltescu A.R.; Butnariu M.; Sarac I.; The importance of solubility for new drug molecules. Biomed Pharmacol J 2020,13(2),577-583","journal-title":"Biomed Pharmacol J"},{"key":"ref=8","first-page":"935","volume":"9","author":"Butu M.","year":"2014","unstructured":"Butu M.; Butnariu M.; Rodino S.; Butu A.; Study of zingiberene from lycopersicon esculentum fruit by mass spectometry. Dig J Nanomater Biostruct 2014,9(3),935-941","journal-title":"Dig J Nanomater Biostruct"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3109\/03639045.2011.645830","volume":"38","author":"Jiang T.","year":"2012","unstructured":"Jiang T.; Han N.; Zhao B.; Xie Y.; Wang S.; Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm 2012,38(10),1230-1239","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=10","first-page":"1652","volume":"77","author":"Yaqoubi S.","year":"2015","unstructured":"Yaqoubi S.; Barzegar-Jalali M.; Adibkia K.; Hamishehkar H.; Dry powder inhalation of celecoxib nanoparticles: Formulation and in vitro characterization. Pharm Ind 2015,77(11),1652-1659","journal-title":"Pharm Ind"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejps.2013.08.030","volume":"50","author":"Sarnes A.","year":"2013","unstructured":"Sarnes A.; \u00d8stergaard J.; Jensen S.S.; Aaltonen J.; Rantanen J.; Hirvonen J.; Peltonen L.; Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods. Eur J Pharm Sci 2013,50(3-4),511-519","journal-title":"Eur J Pharm Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","volume":"453","author":"Sinha B.","year":"2013","unstructured":"Sinha B.; M\u00fcller R.H.; M\u00f6schwitzer J.P.; Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm 2013,453(1),126-141","journal-title":"Int J Pharm"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2008.03.002","volume":"128","author":"de Waard H.","year":"2008","unstructured":"de Waard H.; Hinrichs W.L.J.; Frijlink H.W.; A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J Control Release 2008,128(2),179-183","journal-title":"J Control Release"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jddst.2017.10.001","volume":"43","author":"Shariare M.H.","year":"2018","unstructured":"Shariare M.H.; Sharmin S.; Jahan I.; Reza H.M.; Mohsin K.; The impact of process parameters on carrier free paracetamol nanosuspension prepared using different stabilizers by antisolvent precipitation method. J Drug Deliv Sci Technol 2018,43,122-128","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jyp.2013.08.002","volume":"5","author":"Sajeev Kumar B.","year":"2013","unstructured":"Sajeev Kumar B.; Saraswathi R.; Dhanaraj S.A.; Solid-state characterization studies and effect of PEG 20000 and P90G on particle size reduction and stability of complexed glimepiride nanocrystals. J Young Pharm 2013,5(3),83-89","journal-title":"J Young Pharm"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40005-019-00436-0","volume":"50","author":"Parashar P.","year":"2020","unstructured":"Parashar P.; Diwaker N.; Kanoujia J.; Singh M.; Yadav A.; Singh I.; Saraf S.A.; In situ gel of lamotrigine for augmented brain delivery: development characterization and pharmacokinetic evaluation. J Pharm Investig 2020,50(1),95-105","journal-title":"J Pharm Investig"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"469-480","DOI":"10.1007\/s12247-020-09465-x","volume":"16","author":"Pal R.R.","year":"2020","unstructured":"Pal R.R.; Maurya A.K.; Parashar P.; Saraf S.A.; A Comparative Study of Levocetirizine Loaded Vesicular and Matrix Type System for Topical Application: Appraisal of Therapeutic Potential against Atopic Dermatitis. J Pharm Innov 2020,16,469-480","journal-title":"J Pharm Innov"},{"key":"ref=18","first-page":"293","volume":"1","author":"Sharma S.","year":"2010","unstructured":"Sharma S.; Aggarwal G.; Novel technologies for oral delivery of poorly soluble drugs. Res J Pharm Biol Chem Sci 2010,1(4),293-295","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10847-009-9705-8","volume":"67","author":"Semalty A.","year":"2010","unstructured":"Semalty A.; Semalty M.; Singh D.; Rawat M.S.M.; Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 2010,67(3-4),253-260","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijpharm.2014.05.060","volume":"471","author":"Kumar S.","year":"2014","unstructured":"Kumar S.; Gokhale R.; Burgess D.J.; Sugars as bulking agents to prevent nano-crystal aggregation during spray or freeze-drying. Int J Pharm 2014,471(1-2),303-311","journal-title":"Int J Pharm"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11095-008-9791-0","volume":"26","author":"Yen F-L.","year":"2009","unstructured":"Yen F-L.; Wu T-H.; Lin L-T.; Cham T-M.; Lin C-C.; Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm Res 2009,26(4),893-902","journal-title":"Pharm Res"},{"key":"ref=22","first-page":"1","volume":"23","author":"Hussein A.A.","year":"2014","unstructured":"Hussein A.A.; Mahmood H.S.; Preparation and evaluation of cefixime nanocrystals. Iraqi J Pharm Sci (P-ISSN 1683-3597, E-ISSN 2521-3512) 2014,23(2),1-12","journal-title":"Iraqi J Pharm Sci (P-ISSN 1683-3597, E-ISSN 2521-3512)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.supflu.2011.07.008","volume":"59","author":"Youn Y-S.","year":"2011","unstructured":"Youn Y-S.; Oh J.H.; Ahn K.H.; Kim M.; Kim J.; Lee Y-W.; Dissolution Rate Improvement of Valsartan by Low Temperature Recrystallization in Compressed CO: Prevention of Excessive Agglomeration. J Supercrit Fluids 2011,59,117-123","journal-title":"J Supercrit Fluids"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13346-017-0453-9","volume":"8","author":"Singh M.","year":"2018","unstructured":"Singh M.; Kanoujia J.; Parashar P.; Arya M.; Tripathi C.B.; Sinha V.R.; Saraf S.K.; Saraf S.A.; Augmented bioavailability of felodipine through an \u03b1-linolenic acid-based microemulsion. Drug Deliv Transl Res 2018,8(1),204-225","journal-title":"Drug Deliv Transl Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"Bhattacharjee S.","year":"2016","unstructured":"Bhattacharjee S.; DLS and zeta potential - What they are and what they are not? J Control Release 2016,235,337-351","journal-title":"J Control Release"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4314\/tjpr.v12i2.20","volume":"12","author":"Honary S.","year":"2013","unstructured":"Honary S.; Zahir F.; Effect of zeta potential on the properties of nano-drug delivery systems - A review (Part 2). Trop J Pharm Res 2013,12(2),265-273","journal-title":"Trop J Pharm Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molliq.2018.05.129","volume":"2018","author":"Munyalo J.M.","year":"2017","unstructured":"Munyalo J.M.; Zhang X.; Particle size effect on thermophysical properties of nanofluid and nanofluid based phase change materials: a review. J Mol Liq 2017,2018(265),77-87","journal-title":"J Mol Liq"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2165\/00003495-198500292-00005","volume":"29","author":"R\u00f6nn O.","year":"1985","unstructured":"R\u00f6nn O.; Bengtsson B.; Edgar B.; Raner S.; Acute haemodynamic effects of felodipine and verapamil in man, singly and with metoprolol. Drugs 1985,29(2)(Suppl. 2),16-25","journal-title":"Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0002-9149(96)00816-8","volume":"79","author":"Bonaduce D.","year":"1997","unstructured":"Bonaduce D.; Petretta M.; Ianniciello A.; Apicella C.; Cavallaro V.; Marciano F.; Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction. Am J Cardiol 1997,79(5),564-569","journal-title":"Am J Cardiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/hr.2015.30","volume":"38","author":"Klimas J.","year":"2015","unstructured":"Klimas J.; Kruzliak P.; Rabkin S.W.; Modulation of the QT interval duration in hypertension with antihypertensive treatment. Hypertens Res 2015,38(7),447-454","journal-title":"Hypertens Res"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210729104351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195119\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210729104351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T11:21:49Z","timestamp":1669807309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195119\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201818666210729104351","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}